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Abstract
Donor organ transplantation is currently an essential therapeutic approach to the replacement of a dysfunctional organ as a
result of disease, injury or aging in vivo. Recent progress in the area of regenerative therapy has the potential to lead to
bioengineered mature organ replacement in the future. In this proof of concept study, we here report a further
development in this regard in which a bioengineered tooth unit comprising mature tooth, periodontal ligament and
alveolar bone, was successfully transplanted into a properly-sized bony hole in the alveolar bone through bone integration
by recipient bone remodeling in a murine transplantation model system. The bioengineered tooth unit restored enough the
alveolar bone in a vertical direction into an extensive bone defect of murine lower jaw. Engrafted bioengineered tooth
displayed physiological tooth functions such as mastication, periodontal ligament function for bone remodeling and
responsiveness to noxious stimulations. This study thus represents a substantial advance and demonstrates the real
potential for bioengineered mature organ replacement as a next generation regenerative therapy.
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Introduction
Donor organ transplantation is currently essential to replace a
dysfunctional organ and to restore organ function in vivo [1,2]. This
approach is problematic for clinicians however as donor organs are
constantly in short supply [2,3]. An attractive new concept in current
regenerative therapy that may possibly replace conventional trans-
plantation in the future is stem cell transplantation therapy [4,5] or a
two-dimensional uniform cell sheet technique [6,7] to repair the local
sites of the damaged tissues and organs [8]. The ultimate goal of
regenerative therapy in the future is to develop organ replacement
regenerative therapies that will restore lost or damaged tissues fol-
lowing disease, injury, or aging with a fully functioning bioengineered
organ [9,10,11]. To construct a bioengineered organ, one of two
major concepts is to construct fully functional artificial organs using
three-dimensional tissue-engineering technology, involving biode-
gradable materials and various cell types, that can immediately
function after transplantation in vivo [12,13,14]. However, further
technological developments are required to create such artificial
organs which can immediately function [15].
For the regeneration of ectodermal organs such as a tooth, hair
follicle or salivary gland [16,17], a further concept has been
proposed in which a bioengineered organ is developed from
bioengineered organ germ by reproducing the developmental
processes that take place during organogenesis [11,18]. Tooth
regenerative therapy is thought to be a very useful study model for
organ replacement therapies [11,19,20]. The loss of a tooth causes
fundamental problems in terms of oral functions, which are
achieved in harmony with the teeth, masticatory muscles and the
temporomandibular joint under the control of the central nervous
system [21]. It has been anticipated that a bioengineered tooth
could restore oral and physiological tooth functions [19]. We have
previously developed a three-dimensional cell manipulation
method, designated the organ germ method, for the reconstitution
of bioengineered organ germ, such as a tooth or whisker follicle
[22]. This bioengineered tooth erupted with the correct structure,
occluded at the lost tooth region in an adult mouse. It also showed
sufficient masticatory performance, periodontal functions for bone
remodeling and the proper responsiveness to noxious stimulations
[20]. This previous study thus provided a proof of concept that
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e21531successful replacement of an entire and fully functioning organ
could be achieved through the transplantation of bioengineered
organ germ i.e. a successful organ replacement regenerative
therapy [20].
Transplantation of a bioengineered mature organ will lead to
immediately perform of the full functions in vivo and have a
profound impact on the survival outcomes of many diseases [2,9].
Transplanted bioengineered organs are also expected to be viable
over the long-term and achieve the continuous production of
various functional cells and their progenitors from stem cells as
efficiently as the natural organ in vivo [23,24]. It has also been
proposed that mature organs can be developed from bioengi-
neered organ germ by faithfully reproducing in vivo developmental
processes. In the dental treatment, it has been expected to
transplant of a bioengineered tooth unit comprising mature tooth,
periodontal ligament (PDL) and alveolar bone into the tooth loss
region through bone integration, which is connected between
recipient bone and bioengineered alveolar bone in a bioengi-
neered tooth unit [25]. Transplantation of a bioengineered tooth
unit has also been proposed as a viable option to repair the large
resorption defects in the alveolar bone after tooth loss [26].
However, there are currently no published reports describing
successful transplantation or replacement using a bioengineered
tooth [10,27].
In our current study, we have generated a bioengineered tooth
unit, which was controlled for length and shape and report a
successful tooth replacement by transplantation of a bioengineered
tooth unit into the tooth loss region, followed by successful bone
integration, and restoration of tooth physiological functions such
as mastication, PDL function and an appropriate responsiveness to
noxious stimulations. This transplantation of a bioengineered
tooth unit could also regenerate alveolar bone formation in a
vertical direction. Our results thus further demonstrate the
potential for bioengineered tooth replacement as a future
regenerative therapy.
Results
Generation of a Bioengineered Tooth Unit
We have previously reported that bioengineered tooth germ can
successfully develop a bioengineered tooth that by subrenal capsule
transplantation can restore a mature tooth, including periodontal
tissue and alveolar bone [22]. Because a three-dimensional in vitro
organ culture has not yet been developed, we employed a strategy
involving a bioengineered tooth unit, which has the necessary tissues
to restore tooth functions, to investigation and advance the future
potential of bioengineered tooth replacement (figure 1A). The
bioengineered molar tooth germ was developed to a stage equivalent
to the early bell stage of natural tooth germ for 5–7 days in an in vitro
organ culture (figure 1B). Although we have previously reported that
multiple bioengineered teeth have been formed from a bioengi-
neered tooth germreconstituted by our organ germmethod [22], we
recently developed a method to generate a single and width-
controlled bioengineered tooth [28]. The bioengineered tooth germ
gradually accumulated hard tissue, root extension, and an increased
alveolar bone volume, depending on transplantation periods, and
could successfullygenerate atooth unitwith the correctstructureofa
whole molar, and the proper formation of periodontal tissue and
surrounding alveolar bone (figure 1C, D). However, the shape (x vs.
y axis) of the bioengineered tooth unit was flattened by the pressure
of the outer membrane of the subrenal capsule (figure 1F, G). The
length of the tooth also showed continuous root elongation
depending on the transplantation periods without occlusional
mechanical stress (figure 1C, F, H).
To generate the shape- and length-controlled bioengineered
tooth unit so that a suitable size was obtained for intraoral
transplantation, the tooth germ was inserted into a ring-shaped
size-control device and then transplanted into a subrenal capsule
(figure 1E). The crown widths, calculated from the x/y axis ratios,
of natural first, second and third molars of 9-week-old adult mice
were 1.6160.05 mm, 1.0960.04 mm, 1.1260.04 mm, respectively
(each n=5, figure 1G). The crown width of the bioengineered tooth
units grown in the size-control device, which had a 1.8 mm inside
diameter and 1.3 mm thickness, was 1.4660.16 mm whereas when
grown outside of the device the size was 2.3060.35 mm (each n=5,
figure 1G). The device thus successfully generated a size-controlled
bioengineeredtoothsothatitwassimilartoanaturaltooth(figure1F,
G). This device could avoid the pressure by the subrenal capsule
membrane,andreservethethree-dimensionalspacefordevelopinga
bioengineered tooth germ normally. We next evaluated the length of
a bioengineered tooth unit generated in the size-control device
(figure 1E). After 30 or 60 days, the lengths of the teeth transplanted
without the devices were 1.0760.20 mm and 1.7060.26 mm,
respectively, which was significantly associated with the transplan-
tationperiod(eachn=5,figure1H,figureS1A).Althoughthelength
of the bioengineered tooth transplanted without the devices was
1.7060.26 mm after 60 days transplantation, bioengineered teeth
transplanted in devices of 1.3 or 1.8 mm in diameter, was
significantly regulated at 1.0260.11 or 1.2760.06 mm, respectively
(each n=5, figure 1H). The shape and length of the bioengineered
tooth unit can therefore be controlled in three-dimensions using a
specialized device.
Multiple bioengineered tooth units surrounded by alveolar bone
could be also generated by the transplantation of several tooth
germs into a single size-control device (figure 1I, figure S1B). Each
resulting tooth had the correct structure including pulp cavities
and partitioned periodontal spaces (figure 1I, figure S1C). Hence,
multiple tooth replacements can be achieved with this regenerative
transplantation method.
Transplantation of a Bioengineered Tooth Unit into a
Tooth Loss Region in Vivo
We next investigated whether a bioengineered tooth unit could
be engrafted via the integration between the alveolar bone of this
unit and that of the host recipient and then function appropriately
by occlusion with an opposing tooth (figure 2A). The bioengi-
neered tooth unit, which was generated by transplantation in a
device of a 2.5 mm inside diameter for 50–60 days and labeled by
the administration of calcein reagent into recipient mouse
(figure 2B), was transplanted with the correct orientation into a
properly-sized bony hole in the lower first molar region of the
alveolar bone in a 4-week-old mouse (figure 2C). Briefly, in this
mouse model, the lower first molar had been extracted, and the
resulting gingival wounds had been allowed to heal for 4–6 days
(figure S2A). When the bioengineered tooth unit was transplanted,
it was located at a position reaching the occlusal plane with the
opposing upper first molar (figure 2C, figure S2A). Partial bone
integration was observed at 14 days after transplantation, and full
bone integration around a bioengineered tooth root was seen at 30
days after transplantation (figure 2C). In the calcein-labeled
alveolar bone of bioengineered tooth unit, resorption was partially
observed at the surface at 30 days post-transplantation (figure 2D,
figure S2B). The calcein-labeled bone finally disappeared and the
recipient bone around the bioengineered tooth root replaced it
completely at 40 days after transplantation at a frequency of 66/83
(79.5%; figure 2C, D, figure S2B). There have been many
previously reported clinical cases of multiple tooth loss, the most
serious condition being edentulism [29]. It is possible that a
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jaw (figure S2E, F). Our current findings suggest that bioengi-
neered teeth can be engrafted into regions of tooth loss through
bone integration, which involves resorption of the alveolar bone of
the bioengineered tooth unit through natural bone remodeling in
the recipient.
The engrafted bioengineered tooth was found to be aligned
appropriately and occlude with the opposing upper first molar
(figure 2E, figure S2C). Micro-CT analysis also revealed that no
root elongation was evident for the bioengineered tooth and that
the apical foramen of the engrafted bioengineered tooth root
significantly narrowed at 40 days after transplantation (each n=9,
figure S2D). These results suggest that the bioengineered tooth in
the tooth unit isolated from subrenal capsule transplantation is
immature tooth, which has the potential to narrow of the apical
foramen after the oral transplantation and would have the
physiological ability to recapitulate mechanical stress by occlusion.
Masticatory potential is essential for proper tooth function and
we next performed a Knoop hardness test, an important measure
of masticatory functions, on bioengineered teeth including both
the dentin and the enamel components. The Knoop hardness
numbers (KHN) of the enamel and dentin in the natural teeth of
11-week-old adult mice were measured at 404.2678.2 and
81.0611.5, respectively (each n=5, figure 2F). The bioengineered
teeth generated in a subrenal capsule (SRC) and in jaw bone (TP)
showed similar KHN values at 179.6649.2 and 319.6678.3 in the
enamel, and 80.7611.5 and 76.8613.6 KHN in the dentin,
respectively (each n=5, figure 2F). The value of enamel Knoop
hardness of natural tooth increase in according to postnatal period
[20]. Although the enamel hardness of the bioengineered tooth
generated in a SRC showed low KHN values, the enamel
hardness of the engrafted bioengineered teeth (TP) increased to
the high KHN value in according to the period after the
transplantation into jaw bone. Therefore, the hardness of the
dentin in the engrafted bioengineered teeth was in the normal
range. These findings indicate that the hardness of the enamel and
dentin in the engrafted bioengineered teeth were in the normal
range.
Functional Analysis of the Periodontal Ligament and
Neurons of the Engrafted Bioengineered Teeth
Previously, it had been demonstrated that the bioengineered
tooth germ can recapitulate physiological tooth function in the
adult murine oral environment [20]. In our present study, we next
investigated whether an engrafted bioengineered mature tooth
unit can also restore physiological tooth functions in vivo such as the
response to mechanical stress and the perceptive potential for
noxious stimulations. It is essential for tooth functions that the
engrafted bioengineered tooth in recipient has the cooperation
with the oral and maxillofacial regions through the PDL. The
response of the PDL to mechanical stress, such as orthodontic
movements, induces alveolar bone remodeling, which is indicated
by the localization of tartrate-resistant acid phosphatase (TRAP)-
osteoclasts and osteocalcin (Ocn) mRNA-positive osteoblasts [20].
During experimental tooth movement, TRAP-positive osteoclasts
and Ocn mRNA-positive osteoblasts were observed on the
compression and tension sides, respectively (figure 3A). This
demonstrated that the PDL of the bioengineered tooth unit
successfully mediates bone remodeling via the proper localization
of osteoclasts and osteoblasts in response to mechanical stress.
The perceptive potential for noxious stimulation including
mechanical stress and pain, are important for proper tooth
function [30]. Trigeminal ganglional neurons, which innervate the
pulp and PDL, can respond to these stimulations and transduce
the perceptions to the central nervous system. Blood vessels that
are detected in the pulp and PDL, maintain dental tissues such as
odontoblasts, pulp, the PDL and alveolar bone. In our current
experiments, we evaluated the responsiveness of nerve fibers in the
pulp and PDL of the engrafted bioengineered tooth to noxious
stimulations. Although von Willebrand Factor (vWF)-positive
blood vessels were observed in the pulp and PDL of the
bioengineered tooth generated in a subrenal capsule, anti-
neurofilament (NF)-immunoreactive nerve fibers could not be
detected (figure 3B, figure S3A, B). However, NF-positive nerve
fibers could be detected in the pulp and PDL of the engrafted
bioengineered tooth in the recipient bone and the neurons merged
with vWF-positive blood vessels (figure 3B). Neuropeptide Y (NPY)
and calcitonin gene-related peptide (CGRP), which are synthe-
sized in sympathetic and sensory nerves, respectively, were also
detected in both the pulp and PDL neurons (figure 3B, figure
S3C–F). We found in our current analyses that c-Fos immuno-
reactive neurons, which are detectable in the superficial layers of
the medullary dorsal horn following noxious stimulations such as
mechanical and chemical stimulation of the intraoral receptive
fields, were present in both normal and bioengineered teeth and
drastically increased in number at two hours after orthodontic
treatment and pulp exposure (figure 3C). These results indicate
that an engrafted bioengineered tooth unit can indeed restore the
Figure 1. Generation of a bioengineered tooth unit. (A) Schematic representation of the generative technology of bioengineered tooth unit.
(B) Phase construct imagery of a bioengineered tooth germ on day 1 (left) and 5 (center) and HE staining (right) of an organ culture on day 5. Scale
bar, 200 mm. E, epithelium; M, mesenchyme. (C) Photographs (upper) and micro-CT images of the external surface area (middle) and cross section
(lower) of a bioengineered tooth unit. Images were captured at 20 days (left), 30 days (center) and 60 days (right) after subrenal capsule
transplantation (SRC). Scale bar, 200 mm. C, tooth crown side; R, tooth root side. (D) Histological analysis of the bioengineered tooth unit on day 30
after SRC transplantation (left). (Scale bar, 500 mm). Higher magnification images of crown area (upper right) and the periodontal tissue area (lower
right) are also shown. Scale bar, 50 mm. E, enamel; D, dentin; AB, alveolar bone; PDL, periodontal ligament. (E) Photographs of the developmental
processes occurring in bioengineered tooth germ in a subrenal capsule (SRC) using a size-control device. Images were captured of bioengineered
tooth germ orientated in the device (top left), transplantation into the SRC (top right), and the bioengineered tooth at 50–60 days after
transplantation in the SRC (middle). Micro-CT images of the external surface area (bottom left) and cross section (bottom left) are also show. The
dotted lines indicate the outlines of the device. Scale bar, 500 mm. (F) Micro-CT images of a bioengineered tooth unit transplanted into the SRC for 30
days with (lower column) or without (upper column) the size-control device at an external (left), axial (center) or cross section (right) view. Scale bar,
500 mm. x, x-axis of the crown; y, y-axis of the crown. (G) X-axis versus y-axis ratios (x/y) of the crowns of bioengineered tooth units at 30 days post
transplantation into an SRC, and also of natural first, second and third molars from 9-week-old mice. Transplantations were performed with or
without the 1.3 mm thickness size-control device. Error bars show the standard deviation (n=5). *P,0.001 (t-test). (H) The lengths of the
bioengineered tooth units generated using size-control devices, which were of a 1.3 mm (Q1.3 mm) or 1.8 mm (Q1.8 mm) inner diameter, at 30 and
60 days post transplantation into an SRC were compared with or without the devices. Error bars show the standard deviation (n=5). *P,0.01 and
**P,0.001 (t-test). (I) Photograph (first figure from the left) and micro-CT images showing external (second figure), axial (third figure) and cross section
(fourth figure) views of a multiple bioengineered tooth units, in which four teeth were contained in one alveolar bone, after 60 days transplantation
into the SRC. Scale bar, 500 mm.
doi:10.1371/journal.pone.0021531.g001
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PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e21531Figure 2. Engraftment and occlusion of a bioengineered tooth unit in a tooth loss model. (A) Schematic representation of the protocol
used to transplant a bioengineered tooth unit in a murine tooth loss model. (B) Photograph (Upper) and sectional image (Lower) of a calcein-labeled
bioengineered tooth unit at 60 days post transplantation in an SRC. Scale bar, 200 mm. (C) Micro-CT images of a bioengineered tooth unit
(arrowhead) in cross section (upper) and frontal section (first and second figures from the lower left) during the processes of bone remodeling and
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the maxillofacial region.
Regeneration of an Extensive Bone Defect by
Transplantation of a Bioengineered Tooth Unit
Tooth loss is well known to cause significant alveolar bone
resorption at the region in question [26]. Although there have
been many studies of bone regenerative therapies [31], more
effective methods to restore extensive bone defects during
treatments such as dental implants are required and anticipated
[26]. We investigated whether the transplantation of a bioengi-
neered tooth unit would regenerate not only the missing tooth but
also the surrounding alveolar bone of the recipient. To analyze
whether such restoration of the alveolar bone occurred after
transplantation, we developed a murine extensive bone defect
model, which was prepared by the extraction of the lower first
molar and then removal of the surrounding alveolar bone to
generate a critical bone defect in the lower first molar region
(figure 4A, figure S4A). When we transplanted a bioengineered
tooth unit into this bone defect, vertical bone formation was
observed from the marginal bone of the recipient at 14 days after
transplantation (figure 4B, C, figure S4B). The regenerative bone
volume post-transplantation significantly increased compared with
a no transplant control (0.3860.07 mm
3 vs. 0.1260.08 mm
3;
each n=4, figure 4C, D), although the height and volume of the
regenerated alveolar bone surrounding the bioengineered teeth
was not completely recovered. These findings indicate that
transplantation of a bioengineered tooth unit can restore a serious
bone defect.
Discussion
We here demonstrate the successful transplantation of a
bioengineered tooth unit, which is a model for a bioengineered
mature organ, into a missing tooth region in vivo and the
subsequent restoration of tooth function by this graft. We also
show that this transplantation can restore the bone volume in both
the vertical and horizontal dimensions in a missing tooth mouse
model with a serious extensive bone defect. These findings indicate
that whole tooth regenerative therapy is feasible through the
transplantation of a bioengineered mature tooth unit. This study
also provides the first reported evidence of entire organ
regeneration through the transplantation of a bioengineered tooth.
Organ replacement regenerative therapy, but not stem cell
transplantation regenerative therapy for tissue repair, holds great
promise for the future replacement of a dysfunctional organ with a
bioengineered organ reconstructed using three-dimensional cell
manipulation in vitro [11,19]. In previous reports, however,
artificial organs, which were constructed with various cells and
artificial materials could not restore functionality and thus are not
a viable option for long-term organ replacement in vivo [15].
Previously, it has been shown that a bioengineered organ can be
grown in vivo in amphibian models in which activin-treated cell
aggregates could form a secondary heart with pumping function
and also regenerate eyes that were light responsive and connected
with the host nervous system [32,33]. Recently, we have also
regenerated bioengineered organ germs, including tooth germs
and whisker follicles, and successfully achieved a fully functioning
tooth replacement in an adult mouse through the transplantation
of a bioengineered tooth germ in the lost tooth region [20,22]. It
has been anticipated that replacement therapies will be developed
in the future through the transplantation of a bioengineered
mature organ with full functionality and long-term viability [2,19].
In our present experiments, we successfully generated a size-
controlled bioengineered mature tooth unit, a strategy we adopted
because the growth of functional organs in vitro is not yet possible
[27]. Organs require a sufficient mass (cell number) and proper
shape to function [34] and the tooth has unique morphological
features, such as the tooth crown width and length (macro-
morphology), and cusp and root shape (micro-morphology) [35].
However, the technology to regulate tooth morphogenesis for
whole tooth regeneration remains unexplored [36]. We recently
developed a novel organ germ method to regulate the crown width
by regulating the contact area between epithelial and mesenchy-
mal cell layers [28]. In our previous work, we demonstrated that
the length of the bioengineered tooth is equivalent to that of
natural tooth after the transplantation of the bioengineered tooth
germ into oral environment [20]. In this study, the length of the
bioengineered tooth unit could be controlled longitudinally, which
would be provided by the limited space of the device. These
findings provide the first evidence that the bioengineered tooth can
be controlled in three-dimensions using a specialized device. It is
also thought that bioengineered teeth could be generated with a
controlled crown width through cell manipulation and tooth
length by placement in a size-controlling device, which places a
three-dimensional spatial limitation on size [20,28].
Loss of teeth and functional disorders in the PDL or
temporomandibular joint, cause fundamental problems for oral
functions, such as enunciation, mastication and occlusion, and
associated health issues [21]. Although, missing teeth are
traditionally restored by replacement with an artificial tooth, such
as a bridge, denture or osseo-integrated dental implant, it is
thought that the proper restoration of tooth functions will require
bone remodeling regulated by the PDL [20] and a proper
responsiveness to noxious stimulations [30]. Previous reports of
autologous tooth transplantations have indicated that natural
periodontal tissue on the tooth could restore the physiological
tooth function, including bone remodeling [37]. We recently
showed that a fully functional bioengineered tooth can be achieved
through the transplantation of a bioengineered organ germ [20].
In our current study, we demonstrate the successful replacement of
an entire and fully functional tooth unit in vivo, which restored
masticatory potential, the functional responsiveness, including
bone remodeling, of the periodontal tissue to mechanical stress
and proper responsiveness to noxious stimulations via both
peripheral sensory and sympathetic nerves. This is a significant
connection between the recipient jaw bone and alveolar bone of the tooth unit. Histological analysis of the engrafted bioengineered tooth unit at 40
days post transplantation was also performed. (Scale bar, 500 mm and 100 mm in the lower and higher magnification figure; third and fourth figure
from the lower left). NT, natural tooth; BT, bioengineered tooth; AB, alveolar bone; PDL, periodontal ligament. (D) Sectional images of a calcein-labeled
bioengineered tooth unit at 14, 30 and 40 days post-transplantation. The calcein-labeled bone of the bioengineered tooth units (arrowhead) was
found to gradually decrease from the outside and finally disappear at 40 days post-transplantation. Scale bar, 500 mm( upper), 50 mm( lower). NT,
natural tooth; BT, bioengineered tooth. (E) Oral photographs (upper) and micro-CT (lower) images showing occlusion of natural (left) and
bioengineered teeth (right). Scale bar, 500 mm. (F) Assessment of the hardness of a bioengineered tooth. Knoop microhardness values of the enamel
(upper) and dentin (lower) of a bioengineered tooth at 60 days post-transplantation in a subrenal capsule (SRC) and at 40 days post-transplantation in
jawbone (TP) were compared with those of natural teeth in 11-week-old mice. Error bars show the standard deviation (n=5). *P,0.01 (t-test).
doi:10.1371/journal.pone.0021531.g002
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which the transplantation of a bioengineered mature organ, and
not organ germ, can replace an organ and restore its full function.
In order for a tooth to cooperate with the maxillofacial region, it
is supported by the connection between the root cementum and
alveolar bone through the PDL, which has essential roles in tooth
support, resorption and repair of the root cementum, and the
remodeling of alveolar bone [38]. Tooth loss causes a large
amount of alveolar bone resorption, which is mediated by the
PDL, in the vertical and horizontal dimensions, and the loss of this
bone, which leads to both functional and aesthetic problems, is
difficult to rectify with standard dental therapies such as dental
implant and autologous tooth transplantation [26]. Although bone
regeneration has been attempted for many years through the use
of tissue engineering technologies, guided bone regeneration
methods, autologous bone or cell transplantation, and cytokine
Figure 3. Experimental tooth movement and pain response to mechanical stress. (A) Sections of natural and bioengineered teeth were
analyzed by TRAP-staining and in situ hybridization analysis of Ocn mRNA at day 6 of orthodontic treatment. TRAP-positive cells (arrow) and Ocn
mRNA-positive cells (arrowhead) are indicated. Scale bar, 100 mm. (B) Nerve fibers and blood vessels in the pulp and PDL of a natural tooth (top), a
bioengineered tooth unit in an SRC (middle), and a bioengineered tooth at 40 days after transplantation (bottom) were analyzed
immunohistochemically using specific antibodies for neurofilament (NF; green) and von Willebrand Factor (vWF; red). Scale bar, 50 mm. D, dentin;
P, pulp; AB, alveolar bone; PDL, periodontal ligament. (C) Analysis of c-Fos immunoreactive neurons in the medullary dorsal horns of mice after
0 hours (no stimulation, control; top), 2 hours of stimulation by orthodontic force (middle) and pulp exposure (bottom). C-Fos (arrowhead) was
detectable after these stimulations in both natural (left) and bioengineered teeth at 40 days post-transplantation (right). Scale bar, 100 mm. T, spinal
trigeminal tract.
doi:10.1371/journal.pone.0021531.g003
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PLoS ONE | www.plosone.org 7 July 2011 | Volume 6 | Issue 7 | e21531Figure 4. Alveolar bone regeneration following the transplantation of a bioengineered tooth unit. (A) Schematic representation of a
murine extensive bone defect model and the transplantation of a bioengineered tooth unit (arrowhead). (B) Micro-CT images of the vertical alveolar
bone regeneration processes in a no transplantation control (upper) and following the transplantation of a bioengineered tooth unit (arrowhead,
lower) in a murine extensive bone defect model. Vertical bone formation was observed from the marginal bone of the recipient (arrow). Scale bar,
500 mm. (C) Three-dimensional superposition of micro-CT images of natural dentition (gray, double dotted line), a transplanted bioengineered tooth
unit (lower) and a no transplantation control (upper) at day 0 in an extensive bone defect (red, straight line), and at 45 days after transplantation
(green, dotted line). The superior edges of the recipient alveolar bone are indicated by each line. (D) Regenerative bone volume of the buccal area
following the transplantation of a bioengineered tooth unit (transplant) and no transplantation (control) at day 45 in an extensive bone defect. Error
bars show the standard deviation (n=4). *P,0.01 (t-test).
doi:10.1371/journal.pone.0021531.g004
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bone regeneration in the vertical and horizontal dimensions has
been established yet [31]. In our present study however, we
demonstrate that a bioengineered tooth unit could be engrafted
and integrate via recipient bone remodeling after transplantation
into an extensive bone defect. The recipient alveolar bone of the
vertical dimension was observed to maintain the height of the PDL
in the bioengineered tooth unit. These findings indicate that the
transplantation of a bioengineered tooth has great potential for not
only future whole tooth regenerative therapy but also as a
treatment in clinical cases where tooth loss is accompanied by a
serious alveolar bone defect.
Further studies of three-dimensional organ culture technologies
in vitro, which can generate a fully functional bioengineered organ,
and the identification of available adult tissue stem cells for the
reconstitution of a bioengineered tooth germ will be required in
the future to realize whole tooth regenerative therapy in the clinic.
Materials and Methods
Ethics Statement
All animals and experimental protocols were approved by the
Tokyo University of Science Animal Care and Use Committee
(Permit Number: N10018). All surgery was performed under
sodium pentobarbital anesthesia, and all efforts were made to
minimize suffering.
Reconstitution of a bioengineered tooth germ from
single cells
Molar tooth germs were dissected from the mandibles of
ED14.5 mice. The isolation of tissues and single cell preparations
from the epithelium and mesenchyme has been described
previously [22]. Dissociated epithelial and mesenchymal cells
were precipitated by centrifugation in a siliconized microtube and
the supernatant was completely removed. The cell density of the
precipitated epithelial and mesenchymal cells after the removal of
the supernatants reached a concentration of 5610
8 cells/ml [22].
Bioengineered molar tooth germ was reconstituted using our
previously described 3-dimensional cell manipulation technique,
the organ germ method [22]. We used 5610
4 epithelial and
mesenchymal cells each to generate single tooth structures. The
bioengineered tooth germs were incubated for 10 min at 37uC,
placed on a cell culture insert (0.4 mm pore diameter; BD, Franklin
Lakes, New Jersey, USA), and then further incubated at 37uC for
five days in an in vitro organ culture as described previously [22].
Generation of a bioengineered tooth unit
To control the length and shape of the bioengineered tooth unit,
we manufactured a plastic ring-shaped structure, which was used
as a size-control device, of a 1.3, 1.8 or 2.5 mm inside diameter
and 1.3 mm thickness. After five days of cultivation, the
reconstituted tooth germs were placed into this spacing device
which was transplanted into a subrenal capsule for 60 days using
7-week-old female mice as the hosts. The bioengineered tooth unit
was then isolated from the device.
Fluorescent calcein labeling
Calcein (Wako, Osaka, Japan) was administered daily (1.6 mg/kg)
via a subcutaneous dose to the transplanted bioengineered tooth
germ in the subrenal capsule. These tooth units were then
transplanted into the extracted regions of a lower first molar for 14,
30 or 40 days. Non-decalcified frozen sections were then prepared
and observed using an Axiovert (Carl Zeiss, Oberkochen, Germany)
with AxioCAM MRc5 (Carl Zeiss).
Transplantation
The lower first molars of 4-week-old C57BL/6 (SLC, Shizuoka,
Japan) mice were extracted under deep anesthesia and the
resulting gingival wounds had been allowed to heal for 4–6 days.
The transplantation of a bioengineered tooth unit was allowed the
procedure as described previously [20]. To generate an extensive
alveolar bone defect mouse model, the whole supporting alveolar
bone (1.5 mm mesiodistally, 1.2 mm buccolingually and 0.6 mm
vertically) was removed using a dental engine (NSK, Tochigi,
Japan) under deep anesthesia. The bioengineered tooth units were
transplanted into these defects using the same procedure described
above.
Microcomputed Tomography (Micro-CT)
The heads of the mice that had received a transplanted
bioengineered tooth unit and normal mice were arranged in the
centric occlusal position and radiographic imaging was then
performed by x-ray using a Micro-CT device (R_mCT; Rigaku,
Tokyo, Japan) with exposure at 90 kV and 150 mA. Micro-CT
images were captured using i-view R (Morita, Kyoto, Japan) and
Imaris (Carl Zeiss).
Histochemical analysis and immunohistochemistry
Histochemical and immunohistochemical tissue analyses were
performed as described previously [20,22].
Hardness measurements
Polished enamel and dentin samples from bioengineered tooth
units extracted at 60 days after germ transplantation into the SRC
or the mandible, and also a normal tooth (9-week postnatal) were
embedded in acrylic resin (n=5 for each group). The Knoop
hardness test was then performed using a Miniload Hardness
Tester (HM-102; Mitutoyo, Kanagawa, Japan) equipped with a
Knoop diamond tip (19BAA061; Mitutoyo). Five indentations
were made on each specimen with a 10 g load for 10 sec.
Experimental orthodontic treatments
Orthodontic treatment was performed as described previously
[20]. Experimental tooth movements consisted of a horizontal
orthodontic force of about 10–15 g applied continuously to the
bioengineered tooth of the mice in the experimental group in a
buccal direction using a dial tension gauge (Mitutoyo) for six days.
In the control group, orthodontic force was applied in the buccal
direction to the first molars of 7-week-old normal C57BL/6 mice
in the same manner as the experimental group. Serial sections at
day 6 were analyzed by TRAP staining and by in situ hybridization
analysis for osteocalcin (Ocn) mRNA as previously described [20].
Pulp exposure
A minimal pinpoint mechanical exposure of the pulp was made
in the bioengineered tooth or control natural first molar of mice
under anesthesia using a dental engine (NSK) supplied with dental
diamond point (Shofu, Kyoto, Japan). For stimulation with cold
water, ice was applied to the cavity of the tooth after pulp
exposure.
Measurement of the regenerative bone volume
To evaluate the extent of the alveolar bone recovery in our
extensive bone defect mouse model, we used the Micro-CT device
(Rigaku) to measure alveolar bone volume of the treated areas at 0
and 45 days after transplantation. We measured the volume of the
alveolar bone in the operated region using TRI/3D-BON
software (Ratoc, Osaka, Japan). The 3D region of interest (ROI)
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from the medial edge of lower second molar to the distal edge of
the foramen mentale. We subtracted the alveolar bone volume of
the area at day 0 from the volume at day 45, and calculated the
regenerated bone volume.
Statistical analysis
Statistical significance was determined with the unpaired
Student’s t-test, analyzed using the Common Gateway Interface
Program (twk, Saint John’s University).
Supporting Information
Figure S1 A method for controlling the size of a
bioengineered tooth unit. (A) Micro-CT images of the shapes
of a bioengineered tooth unit, size controlled by devices of a 1.3 or
1.8 mm inner diameter, at 30 and 60 days after transplantation in
an SRC. Scale bar, 500 mm. (B) Photograph of plural bioengi-
neered tooth germ arranged in a size controlled device. Scale bar,
500 mm. (C) Micro-CT images (left) and histological analysis of the
multiple bioengineered tooth units on day 60 after SRC
transplantation (middle and right). The alveolar bone between the
bioengineered teeth is indicated by arrowheads (lower left). Scale
bar, 200 mm. Higher magnification images of the periodontal
tissue area (lower middle and right) are also shown. Scale bar, 50 mm.
D, dentin; AB, alveolar bone; PDL, periodontal ligament.
(TIF)
Figure S2 Engraftment and establishment of occlusion
of a bioengineered tooth unit at the tooth loss region. (A)
Oral photographs and micro-CT images of bioengineered tooth
unit transplantations into the adult mandible. Images were
captured of lateral (top), occlusal (middle) and cross sections (bottom)
views. The bioengineered tooth unit is indicated by an arrowhead.
Scale bar, 500 mm. (B) Sectional images of a calcein-labeled
bioengineered tooth unit at 14, 30 and 40 days after transplan-
tation into a murine model. Fluorescent and DIC images are
merged. The alveolar bone of the bioengineered tooth unit is
indicated by arrowheads. Scale bar, 500 mm, upper; 100 mm, lower.
NT, natural tooth; BT, bioengineered tooth. (C) Oral photographs
of an engrafted bioengineered tooth in a lateral view (upper left), a
45-degree view (lower left), an occlusal view (upper right) and a
fluorescent image (lower right). Scale bar, 500 mm. (D) Measure-
ments of the tooth length (left) and apical foramen width (right)o fa
bioengineered tooth at day 0 and day 40 after transplantation.
Error bars show the standard deviation (n=9). *P,0.05 (t-test). (E)
Schematic representation of the protocol for transplanting
multiple bioengineered tooth units in a murine edentulous model.
(F) Micro-CT images of transplanted multiple bioengineered tooth
units in a murine edentulous model. Images were captured of the
external surface area (left), sagittal section (center) and cross section
(right). The bioengineered teeth are indicated by the arrowheads in
the left figure. Scale bar, 500 mm.
(TIF)
Figure S3 Regeneration of nerve fibers and blood
vessels in the engrafted bioengineered tooth unit. (A, B)
Nerve fibers and blood vessels in the pulp (A) and PDL (B) of a
natural tooth (top), bioengineered tooth unit in an SRC (middle) and
bioengineered tooth at 40 days after transplantation into an oral
tooth loss region (bottom) were analyzed immunohistochemically
using specific antibodies for NF and vWF. DIC (first columns from the
left), NF images (second columns), vWF images (third columns), and
merged images (fourth columns) are shown. Scale bar, 50 mm. (C, D)
Nerve fibers in the pulp (C) and PDL (D) of a natural tooth (top),
bioengineered tooth unit in an SRC (middle) and bioengineered
tooth at 40 days after transplantation (bottom) were analyzed
immunohistochemically using specific antibodies for NF and
neuropeptide Y (NPY). DIC (first columns from the left), NF images
(second columns), NPY images (third columns), and merged images
(fourth columns) are shown. Scale bar, 50 mm. (E, F) Nerve fibers in
the pulp (E) and PDL (F) of a natural tooth (top), bioengineered
tooth unit in an SRC (middle) and bioengineered tooth at 40 days
after transplantation (bottom) were analyzed immunohistochemi-
cally using specific antibodies for NF and calcitonin gene-related
peptide (CGRP). DIC (first columns from the left), NF images (second
columns), CGRP images (third columns), and merged images (fourth
columns) are shown. Scale bar, 50 mm.
(TIF)
Figure S4 Alveolar bone regenerative potential of a
bioengineered tooth unit. (A) Photographs of a lateral (left) and
occlusal (right) view of a natural mandibular dentition and an
extensive bone defect (arrowhead). Scale bar, 500 mm. (B) Micro-
CT images of the frontal section of a no transplantation control
(upper) and a transplanted bioengineered tooth unit at day 45 in a
murine extensive bone defect model (lower). Significant vertical
bone regeneration was observed following the transplantation of a
bioengineered tooth unit when compared with the no transplan-
tation control. The regenerated alveolar bone is indicated by an
arrow. Scale bar, 500 mm.
(TIF)
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